Skip to content

Clinical Study on Integrated Traditional Chinese and Western Medicine Based on the "Qingjie Huagong Method" for Acute Pancreatitis

Clinical Study on Integrated Traditional Chinese and Western Medicine Based on the "Qingjie Huagong Method" for Acute Pancreatitis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001735
Enrollment
Unknown
Registered
2025-09-15
Start date
2024-12-15
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pancreatitis

Interventions

Experimental group:Combined TCM-WM Three-Pronged Approach'Collaborative Regimen with Standard WM Therapy

Sponsors

The Firse Affiliated Hospital of Guangxi University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Aged 18-60 years;Meets both Western and Traditional Chinese Medicine diagnostic criteria for acute pancreatitis; TCM syndrome differentiation confirming either:Blood stasis and toxin accumulation pattern or Liver-gallbladder dampness-heat pattern or Fu-organ excess heat pattern;Good compliance with no history of Chinese herbal medicine allergy;Patients and their family members understand and sign informed consent forms.

Exclusion criteria

Exclusion criteria: Patients with gastrointestinal diseases who cannot tolerate enteral nutrition;Patients with severe underlying conditions including:Poorly controlled diabetes mellitus Hematologic disorders Malignant tumors Hepatic or renal insufficiency;Pregnant or lactating women; Patients with neurological disorders schizophrenia or infectious diseases; Patients with allergic constitution or a history of multiple drug allergies; Patients who have participated in other drug clinical trials within the past 1 month; Patients deemed ineligible by the investigator due to:Inability to complete the study or Non-compliance with study requirements including administrative or other reasons.

Design outcomes

Primary

MeasureTime frame
Severe case rate;Mortality;Effective rate;Length of Hospital Stay;Medical Expenses;abdominal pain symptoms;Telling a doctor about vomiting;Presence of Bowel Sounds;Defecation;

Secondary

MeasureTime frame
White blood cell;C reactive protein;procalcitonin;Sequential Organ Failure Assessement;Acute Physiology And Chronic Health Evaluation II;Glasgow Coma Scale;Marshall MODS Score;TCM Syndrome Efficacy Score;

Countries

China

Contacts

Public ContactChen Guozhong

The Firse Affiliated Hospital of Guangxi University of Chinese Medicine

cheninjp@163.com13407731446

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026